Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001615219-22-000019)

Filing Details

Accession Number:: 0001615219-22-000019
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-03-09 16:03:00
Reporting Period:: 2022-03-03

Accepted Time:: 2022-03-09 16:03:00
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1615219	Salarius Pharmaceuticals Inc.	SLRX	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1329154	J Mark Rosenblum	C/O Salarius Pharmaceuticals, Inc. 2450 Holcombe Blvd., Suite X Houston TX 77021	Exec Vp Finance, Cfo	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2022-03-03	76,246	$0.39	110,319	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

The Registrant issued these shares to the reporting person as part of his bonus; which shares were issued in lieu of net cash compensation. The shares were issued at the fair market value of the Registrants common stock on the date of grant.